Hint mode is switched on Switch off

Reviva Pharmaceuticals, ordinary share
RVPH, US76152G1004

Add a stock to WL
Choose all Reset all
Reviva Pharmaceuticals, сountry — USA
04/06/2026 stock stopped trading due to affiliation to Reviva Pharmaceuticals, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Reviva Pharmaceuticals Inc (formerly Tenzing Acquisition Corp) intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage ...
Reviva Pharmaceuticals Inc (formerly Tenzing Acquisition Corp) intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage in any other similar business combination with one or more businesses or entities.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Reviva Pharmaceuticals Inc (formerly Tenzing Acquisition Corp)
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RVPH
  • Placement
    28.05.2021
  • Lock up period
    180
  • Number of papers
    8,000,000
  • Volume of raised funds
    30 mln USD
  • Placement share
    46.43%
  • Final placement price
    3.75 USD
  • Price change since placement date
    -84.13%
  • By capitalization
    64.62 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RVPH
  • Placement
    07.09.2022
  • Lock up period
    180
  • Number of papers
    1,976,285
  • Volume of raised funds
    5 mln USD
  • Placement share
    9.67%
  • Final placement price
    2.53 USD
  • Price change since placement date
    -76.48%
  • By capitalization
    51.72 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RVPH
  • Placement
    26.06.2025
  • Lock up period
    180
  • Number of papers
    20,000,000
  • Volume of raised funds
    10 mln USD
  • Placement share
    29.41%
  • Final placement price
    0.5 USD
  • Price change since placement date
    19%
  • By capitalization
    34 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
III q eng
IV q eng
Show all Hide

Indicators

News

15/04/2026 Reviva Pharmaceuticals: , Including The Information Contained In Exhibit 99.1, Is Being Furnished To The Securities And Exchange Commission, And Shall Not Be Deemed To Be “filed” For The Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, And Shall Not Be Deemed To Be Incorporated By Reference Into Any Filing Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Shall Be Expressly Set Forth By A Specific Reference In Such Filing
04/03/2026 Reviva Pharmaceuticals: Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
20/01/2026 Reviva Pharmaceuticals: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard, Other Events
18/12/2025 Reviva Pharmaceuticals: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
24/10/2025 Comparative Analysis of Biopharmaceutical Companies on NASDAQ
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.